Literature DB >> 25868122

Building Trust: The History and Ongoing Relationships Amongst DSD Clinicians, Researchers, and Patient Advocacy Groups.

A C Lossie1, J Green2.   

Abstract

Individuals born with differences or disorders of sex development (DSD) have been marginalized by society and the health care system. Standards of care in the mid-20(th) century were based on fixing the child with a DSD, using hormonal and surgical interventions; these treatments and the diagnoses were almost never disclosed to the child, and sometimes they were not disclosed to the parents. This led to secrecy, shame, and stigma. When these children became adults and demanded access to their medical records, the realization of the depth of secrecy led to the formation of activism groups that shook the medical community. Despite precarious beginnings, advocates, health care professionals, and researchers were able to elicit changes in the standard of care. The 2006 Consensus Statement on Management of Intersex Disorders called for a multidisciplinary approach to care and questioned the evidence for many of the standard procedures. Standard of care moved from a concealment model to a patient-centered paradigm, and funding agencies put resources into determining the future paths of research on DSD. Recognition of the need to address patient priorities led to changing international standards for including patients in research design. Some challenges that remain include: the findings from the Institute of Medicine that sexual and gender minorities experience poor health outcomes; establishing trust across all parties; developing a common language and creating venues where individuals can participate in dialogue that addresses personal experiences, research design, clinical practices and intervention strategies. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2015        PMID: 25868122     DOI: 10.1055/s-0035-1548793

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  8 in total

1.  Introduction to the Special Section: Disorders of Sex Development.

Authors:  David E Sandberg; Vickie Pasterski; Nina Callens
Journal:  J Pediatr Psychol       Date:  2017-06-01

Review 2.  Disorders of Sex Development/Intersex: Gaps in Psychosocial Care for Children.

Authors:  Michelle M Ernst; Lih-Mei Liao; Arlene B Baratz; David E Sandberg
Journal:  Pediatrics       Date:  2018-08       Impact factor: 7.124

3.  The impact of culture on disclosure in differences of sex development.

Authors:  Erica M Weidler; Karen E Peterson
Journal:  Semin Pediatr Surg       Date:  2019-09-13       Impact factor: 2.754

Review 4.  Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.

Authors:  Hedi L Claahsen-van der Grinten; Phyllis W Speiser; S Faisal Ahmed; Wiebke Arlt; Richard J Auchus; Henrik Falhammar; Christa E Flück; Leonardo Guasti; Angela Huebner; Barbara B M Kortmann; Nils Krone; Deborah P Merke; Walter L Miller; Anna Nordenström; Nicole Reisch; David E Sandberg; Nike M M L Stikkelbroeck; Philippe Touraine; Agustini Utari; Stefan A Wudy; Perrin C White
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

Review 5.  Neonatal Sex Assignment in Disorders of Sex Development: A Philosophical Introspection.

Authors:  V Raveenthiran
Journal:  J Neonatal Surg       Date:  2017-08-10

6.  Navigating Surgical Decision Making in Disorders of Sex Development (DSD).

Authors:  Melissa Gardner; David E Sandberg
Journal:  Front Pediatr       Date:  2018-11-19       Impact factor: 3.418

Review 7.  Assessing the health-related management of people with differences of sex development.

Authors:  Martina Jürgensen; Marion Rapp; Ulla Döhnert; Fabian-Simon Frielitz; Faisal Ahmed; Martine Cools; Ute Thyen; Olaf Hiort
Journal:  Endocrine       Date:  2021-01-30       Impact factor: 3.633

8.  Long-Term Results of Surgical Treatment and Patient-Reported Outcomes in Congenital Adrenal Hyperplasia-A Multicenter European Registry Study.

Authors:  Susanne Krege; Henrik Falhammar; Hildegard Lax; Robert Roehle; Hedi Claahsen-van der Grinten; Barbara Kortmann; Lise Duranteau; Agneta Nordenskjöld
Journal:  J Clin Med       Date:  2022-08-08       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.